// App-Quantinova.ai

147 : Antibiotic treatment prior to immune checkpoint inhibitor therapy as a tumor-agnostic predictive correlate of response in routine clinical practice.

Researchers

Presenter

  • David James Pinato

Principal Investigators

  • Diego Ottaviani

  • Heather Urus

  • Aisha Patel

  • Takashi Mineo

  • Cathryn Brock

  • Danielle Power

  • Olivia Hatcher

  • Alison Falconer

  • Manasi Ingle

  • Anna Brown

  • Dorothy M. Gujral

  • Sarah Partridge

  • Naveed Sarwar

  • Michael Gonzalez

  • Maggie Bendle

  • Conrad R. Lewanski

  • Thomas Newsom-Davis

  • Mark Bower

Medical Centers

  • Imperial College, London, United Kingdom

  • Kings College London, London, United Kingdom

  • Chelsea and Westminster Hospital, London, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • Charing Cross Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom

  • Charing Cross Hospital, London, United Kingdom

  • Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom

  • Chelsea and Westminster Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved